Summary
BUWA Chart
Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause
The U.S. Government plans to cut the annual budget allocated to the NIH by 40% in 2026. This decision could have an adverse effect on the operations of Bio-Rad. Bio-Rad projects 0.5% revenue growth for 2025, indicating that it encounters problems in expanding its operations. The four relative valuations conducted in this article reported mixed results. These results suggest that the company trades at fair value.
Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants Jonathan P. DiVincenzo - President & COO Norman D.
Earnings Preview: Bio-Rad Laboratories (BIO) Q2 Earnings Expected to Decline
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bio-Rad Laboratories Inc. Dividends
Bio-Rad Laboratories Inc. Earnings
| 30 Oct 2025 (In 2 months) Date | | 1.95 Cons. EPS | - EPS |
| 28 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 31 Jul 2025 Date | | 1.75 Cons. EPS | - EPS |
| 30 Jul 2025 Date | | - Cons. EPS | - EPS |
| 5 May 2025 Date | | - Cons. EPS | - EPS |
| 30 Oct 2025 (In 2 months) Date | | 1.95 Cons. EPS | - EPS |
| 28 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 31 Jul 2025 Date | | 1.75 Cons. EPS | - EPS |
| 30 Jul 2025 Date | | - Cons. EPS | - EPS |
| 5 May 2025 Date | | - Cons. EPS | - EPS |
Bio-Rad Laboratories Inc. (BUWA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Bio-Rad Laboratories Inc. ever had a stock split?
Bio-Rad Laboratories Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Norman D. Schwartz CEO | XSTU Exchange | US0905722072 ISIN |
| US Country | 7,700 Employees | - Last Dividend | 8 Mar 2002 Last Split | - IPO Date |
Overview
Bio-Rad Laboratories, Inc., founded in 1952 and based in Hercules, California, is a prominent provider of life science research and clinical diagnostic products globally, serving customers in the United States, Europe, Asia, Canada, and Latin America. The company operates in two key segments: Life Science and Clinical Diagnostics. With a strong commitment to innovation and quality, Bio-Rad develops, manufactures, and distributes a wide range of instruments, systems, reagents, and consumables designed to advance scientific understanding and improve healthcare outcomes. The firm distributes its offerings through a direct sales force, alongside a network of distributors, agents, brokers, and resellers, ensuring broad and effective market reach.
Products and Services
Bio-Rad Laboratories, Inc. offers a vast array of products and services tailored to meet the needs of various markets, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety, as well as clinical diagnostics.
- Life Science Research Products:
These include instruments, systems, reagents, and consumables for the separation, purification, characterization, and quantitation of biological materials like cells, proteins, and nucleic acids. These products support critical research areas in proteomics and genomics, empowering scientists to make groundbreaking discoveries in biology and medicine.
- Clinical Diagnostics Products:
Bio-Rad offers an extensive range of test systems, informatics systems, test kits, and specialized quality controls. These are designed for application in various settings including hospitals, diagnostic reference labs, transfusion services, and physician office laboratories. The clinical diagnostics segment focuses on providing accurate and reliable tools for the diagnoses of diseases and the monitoring of treatment efficacy.
- Biopharmaceutical Production Supplies:
This range supports the production of biopharmaceuticals with a focus on the purification and analysis of biological materials. Bio-Rad's products in this category are essential for ensuring the safety and efficacy of biopharmaceuticals, including vaccines, antibodies, and therapeutic proteins.
- Food Safety Testing Products:
Bio-Rad also provides robust solutions for testing the safety of food products. These include reagents, instruments, and systems that help detect potentially harmful contaminants in food, ensuring compliance with international food safety standards and protecting public health.
Contact Information
